谷类 发表于 2025-3-25 04:48:12
Richard J. Cote,Ram H. DatarProvides a blueprint on how circulating tumor cells can be employed in the future.Features authors from diverse backgrounds in biology, biochemistry, and medical oncology?.Delivers a “one-stop” text tpalpitate 发表于 2025-3-25 11:10:47
http://reply.papertrans.cn/23/2267/226644/226644_22.png主动 发表于 2025-3-25 13:25:58
Helge Großhans,Saibal Chatterjeeard to metastasis biology and treatment. We also consider the clinical impact of monitoring for CTCs in the absence of symptomatic tumor recurrence and what is needed for such an approach to providing “actionable” information that will improve patient outcome.生锈 发表于 2025-3-25 17:38:43
microRNA Biogenesis and Function, regulated, both naturally in the body and therapeutically. A better understanding of mechanisms by which dormancy can be regulated may suggest new therapeutic approaches to either eliminate dormant cancer cells or promote the maintenance of dormancy.Transfusion 发表于 2025-3-25 22:00:35
http://reply.papertrans.cn/23/2267/226644/226644_25.pngelucidate 发表于 2025-3-26 01:46:42
http://reply.papertrans.cn/23/2267/226644/226644_26.pngcultivated 发表于 2025-3-26 05:15:51
http://reply.papertrans.cn/23/2267/226644/226644_27.pngPLUMP 发表于 2025-3-26 09:09:12
http://reply.papertrans.cn/23/2267/226644/226644_28.pnghemoglobin 发表于 2025-3-26 15:27:02
K. Purvis,M. Parvinen,K. Gautvik,V. Hanssonto capture CTC based on specific antigen expression. Then we address the downstream molecular and functional characterization of CTC by utilizing these technologies. We also discuss the limitations of affinity-based CTC enrichment.摘要 发表于 2025-3-26 19:30:35
http://reply.papertrans.cn/23/2267/226644/226644_30.png